Fermenters Market worth $1.69 billion by 2023

The fermenters market is estimated at USD 1.13 billion in 2018 and is projected to reach USD 1.69 billion by 2023, growing at a CAGR of 8.4%.

(EMAILWIRE.COM, November 21, 2018 ) The report "Fermenters Market by Application (Food, Beverage, and Healthcare & Cosmetics), Microorganism (Bacteria and Fungi), Process (Batch, Fed-batch, and Continuous), Mode of Operation (Semi-automatic and Automatic), and Region - Global Forecast to 2023", The fermenters market is estimated at USD 1.13 billion in 2018 and is projected to reach USD 1.69 billion by 2023, growing at a CAGR of 8.4% during the forecast period. The market is driven by factors such as the increase in the consumption of fermented food & beverages in developed economies, along with growing awareness about food preservation.

Browse 80 market data Tables and 42 Figures spread through 134 Pages and in-depth TOC on "Fermenters Market - Global Forecast to 2023"

Early buyers will receive 10% customization on this report.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=101132363

The beverages segment is estimated to account for the largest share, by application, in 2018.

Based on application, the fermenters market has been segmented into food, beverages, and healthcare products & cosmetics. The beverages segment estimated to account for the largest share by application of the fermenters market. The demand for alcoholic fermented beverages is increasing along with the market for kombucha, which is an effervescent sweetened black or green tea. With the increasing consumption of fermented beverages in the US and European countries, the production facilities of beer and wine have been increasing across the globe, which in turn reflects an increasing demand for fermenters.

The automatic segment, by mode of operation, is estimated to account for the largest share of the fermenters market in 2018.

Based on the mode of operation, the fermenters market has been segmented into automatic and semi-automatic. The automatic segment is estimated to account for the largest share of the global fermenters market in 2018. Automatic fermenting equipment ensures that fermented food products are manufactured in time to meet the market demand. The incorporation of automatic machinery in the food, beverage, and pharmaceutical industries can be carried out for a large number of products. Automated fermenters are mainly used to optimize and scale up the production of fermented products. The market for automatic machines is growing in developing regions such as Asia Pacific, with the growing demand for fermented beverages such as kombucha, herbal tea, and kefir in countries such as India and China.

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=101132363

The Asia Pacific is projected to dominate the fermenters market in terms of CAGR in 2018.

The Asia Pacific is projected to lead the global market for fermenters in terms of growth rate. One of the factors for this is the increase in economic growth and rapid urbanization. The growing middle-class population, high spending behavior, and increased demand for healthy fermented food & beverage products with natural ingredients drive the growth of the fermenters market. Asia Pacific is among the fastest-growing regions in terms of usage of fermenters to produce microbial cultures for the fermentation of various food & beverage products. The growth in population and rise in per capita income in China, India, and Japan are expected to drive the demand for fermented foods & beverages, which, in turn, drive the demand for fermenters.

This report includes a study of the marketing and development strategies, along with the product portfolios of the leading companies. It includes the profiles of leading companies such as Eppendorf (Germany), Sartorius (Germany), Thermo Fisher Scientific (US), Pierre Guerin SS (France), CerCell ApS (Denmark), Electrolab Biotech (UK), Applikon Biotechnology (Netherlands), GEA Group (Germany), General Electric (US), Bioengineering AG (Switzerland), Zeta Holding (Austria), and bbi-biotech (Germany).